Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Schinus terebinthifolius Raddi (commonly known as 'aroeira' or Brazilian pepper tree) is a plant-derived botanical extract formulated as an intravaginal gel (7.4% concentration) for the treatment of bacterial vaginosis, cervicitis, and vaginitis. Developed and manufactured by Hebron Laboratory (Laboratório Hebron) in Brazil, the gel is marketed under the brand name Kronel. Its therapeutic efficacy is attributed to the complex phytochemical composition of the aroeira extract, which exhibits broad-spectrum antimicrobial, anti-inflammatory, and wound-healing properties against polymicrobial vaginal flora, including *Gardnerella vaginalis* and *Candida* species. Clinical trials, including those conducted in collaboration with the Institute for Maternal/Infant Health (IMIP) in Brazil, have evaluated its efficacy and safety compared to standard therapies like metronidazole gel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on schinus terebinthifolius raddi.